Teoxane Laboratories
Grégory Garnier is a seasoned professional with extensive experience in logistics, quality management, and lean manufacturing. Currently serving as a Lean Manufacturing Specialist at Teoxane Laboratories since May 2022, Grégory has previously held key roles such as Logistics Supervisor at Boston Scientific and Responsable Logistique at Multicuirs SA. Grégory’s expertise encompasses people management, warehouse operations, and process optimization for international subsidiaries. With a strong foundation in quality management as Lean & Quality Manager at Hach-Lange Sàrl, Grégory successfully managed quality teams, drove improvement projects, and ensured compliance with ISO 9001 standards. Prior roles include responsibilities in purchasing, logistics training, and supplier management across various organizations, demonstrating a comprehensive skill set in operational excellence and supply chain management.
This person is not in the org chart
This person is not in any teams
Teoxane Laboratories
1 followers
When Madame Valérie Taupin created TEOXANE Laboratories in Geneva in 2003, her vision was crystal clear: to satisfy the ever demanding aesthetic market with high performance, avant-garde products based on rigorous scientific research. Today our focus remains unchanged. We are dedicated to designing and manufacturing hyaluronic acid dermal fillers and skincare products, applying industry-leading expertise and high-quality standards. Building on a firm commitment to innovation and patient satisfaction, we have strengthened our presence. In 2023, TEOXANE has over 10 subsidiaries and is present in more than 95 countries worldwide. TEOXANE is now confirmed as a major player in aesthetic medicine and skincare, offering effective solutions to practitioners worldwide, helping women and men who want to look and feel their best at all times and help them maintain their beauty in the future. Our core values of Innovation, Culture of Excellence and Independence continue to set us apart and guide our ambitions.